Yıl: 2012 Cilt: 2 Sayı: 2 Sayfa Aralığı: 50 - 56 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Evaluation of serological diagnostic tests for human Brucellosis in an endemic area

Öz:
Amaç: Bruselloz tanısında kullanılan serolojik testlerin klinik kullanılışlılığı çoğu durumlarda açık değildir. Bu çalışma Türkiye’nin endemik bir bölgesinde bu testlerin bruselloz için değerini araştırmayı amaç edindi. Gereç ve yöntem: Bu çalışma Çanakkale Devlet Hastanesinde 2009 yılında yapıldı. Retrospektif bir yaklaşımla bruselloz için araştırılan hastaların kayıtları toplandı. Çalışma süresinde 236 kişi (131 semptomatik, 105 semptomatik olmayan) brusella tanısı için araştırıldı. Tüm hastalardan alınan örnekler Rose Bengal lam testi, STA testi, Brusella Coombs testi, BrucellaCapt ve brusella IgG ve IgM kitleri ile brusella antikor seropozitifliği için test edildi. Bulgular: Bunların 49’u hastanede yatırıldı ve kan kültürleri alındı. Bunlardan dokuzunda Brucella spp. izole edildi (%18,4). Bruselloz için en duyarlı test BrucellaCapt testi idi (%74,0) ve onu çok yakın bir değerle Coombs testi (%72,5) takip ediyordu. RB testinin duyarlılığı %48,1 bulundu. ELISA IgG testi ELISA IgM testine göre daha duyarlı idi (sırasıyla, %65,6’e karşı %49, 6). Tüm çalışılan testler bruselloz için %100 özgül bulundu ancak RB testinin özgüllüğü %96,1 idi. Yapılan tüm brusella testlerinin pozitif prediktivitesi 1 olmakla beraber; negatif prediktivite sadece Coombs ve BrucellaCapt testi için anlamlı bulundu (sırasıyla 0,744 ve 0,755). Diğer serolojik testler 0,50 civarında veya daha aşağı idi ve bu değerler negatif sonuçlar için zayıftı. Sonuç: ELISA IgG ve IgM test sonuçları diğer testlere üstün bulunmadı. İstatistik ROC eğrisi analizine göre Brusella Coombs ve BrucellaCapt testi endemik sahada en değerli serolojik testler olarak bulundu. Semptomlu hastalarda serolojik testler negatif ise bu araştırılmalı ve kısa tekrarlanmalıdır.
Anahtar Kelime:

Konular: Mikrobiyoloji Enfeksiyon Hastalıkları

Endemik bölgede insan Brusellozu için Serolojik tanı testlerinin değerlendirilmesi

Öz:
Objectives: The clinical utility of complementary tests for brucellosis are not clear in many situation. This study aimed to evaluate value of these tests for brucellosis in an endemic area in Turkey.Materials and methods: This study was performed at Çanakkale General Hospital in 2009. In a retrospective approach, records of the patients who evaluated for brucellosis were collected. During the study period, 236 people (131 symptomatic and 105 non-symptomatic) were evaluated for diagnosis of brucellosis. All of the samples from these patients were tested for Brucella antibody seropositivity by RB slide agglutination, standard serum agglutination, Brucella Coombs, BrucellaCapt, and ELISA IgG and IgM tests. Results: In total, 49 symptomatic patients were hospitalized and blood cultures were obtained. Brucella spp. were isolated from nine of them (18.4%).The BrucellaCapt test was found to be the most sensitive for Brucella (74.0%) and close behind it was the Coombs test (72.5%). The sensitivity for the RB test was 48.1%. The ELISA IgG test was found more sensitive for brucellosis than the ELISA IgM test was (65.6% and 49.6%, respectively). All examined tests were found about 100% specific for brucellosis but the RB test was found less specific than the others were (96.1%) Positive predictive value for all tests was about 1 but negative predictive values were only valuable for the Coombs and Brucella Capt test (0.744 and 0.755, respectively). The other serological tests were around and below 0.50, which was weak for negative results.Conclusions: The ELISA IgG and IgM tests were no superior to the other tests. By assessment of receiver operating characteristics (ROC) analysis, the Brucella Coombs and BrucellaCapt tests were found to be the most valuable tests for serological diagnosis of brucellosis in endemic areas. The seronegative tests in the symptomatic patients should be evaluated and repeated in short time.
Anahtar Kelime:

Konular: Mikrobiyoloji Enfeksiyon Hastalıkları
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Joung EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia 2000; p 2386.
  • 2. Esel D, Doganay M, Alp E, Sumerkan B. Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect 2003; 9: 1038-1044.
  • 3. Spink WW, McCullough NB, Hutchings LM, Mingle CK. A standardized antigen and agglutination technic for human brucellosis. Am J Clin Pathol,1954; 24: 496-8.
  • 4. Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis 2003; 46: 241-243.
  • 5. Smits HL, Abdoel TH, Solera J, Clavijo E, Diaz R. Immunochromotographic Brucella-specific immunglobulin M and G lateral flow assays for the serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 2003;10: 1141-1146.
  • 6. Vandepitte J. Serological tests. In: Vandepitte J, Verhaegen J, Engback K, Rohner P, Piot P, Hevak CC, editors. Basic Laboratory Procedures in Clinical Bacteriology, 2nd ed WHO Publification, Geneva, 2003; 135-6.
  • 7. Kerr W R, McCaughey W J, Yce JO, et al. Techniques and interpretations in the serological diagnosis of brucellosis in man. J Med Microbiol 1968 ;1:181-193.
  • 8. Young EJ. Brucella spp. In: Gillespie SH, Hawkey PM, editors. Principles and Practice of Clinical Bacteriology, 2nd ed. John Wiley & Sons Ltd, West Sussex, England, 2006: 265-272.
  • 9. Vancelik S, Guraksin A, Ayyildiz A. Seroprevalance of human brucellosis in rural endemic areas in eastern Turkey. Trop Doc 2008; 38: 42-3.
  • 10. Sahin M, Genc O, Unver A, Otlu S. Investigation of bovine brucellosis in the North-eastern Turkey. Trop Anim Health Prod 2008; 40: 281-6.
  • 11. Kose S, Smits HL, Abdoel TH, Ozbel Y. Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention. J Infect 2006; 53: 308-14.
  • 12. Cetinkaya Z, Aktepe OC, Ciftci IH, Demirel R. Seroprevalence of human brucellosis in a rural area of Western Anatolia, Turkey. J Health Popul Nutr 2005; 23: 137-141.
  • 13. Ertek M, Yazgı H, Ozkurt Z, Ayyildiz M, Parlak M. Comparison of the diagnostic value of the Standard tube agglutination test and the ELISA IgG and IgM in patients with Brucellosis. Turk J Med Sci 2006; 36: 159-163.
  • 14. Cakan G, Bezirci FB, Kacka A, et al. Assessment of diagnostic enzyme-linked immunosorbent assay kit and serological markers in human brucellosis. Jpn J Infect Dis 2008; 61: 366-370.
  • 15. Araj GF, Brown GM, Haj MM, Madhvan NV. Assessment of Brucellosis Card test in screening patients for brucellosis. Epidem Inf 1988; 100: 389-398.
  • 16. Orduna A, Almaraz A, Prado A, et al. Evaluation of immunocapture- agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 2000; 38: 4000-4005.
  • 17. Gomez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vacc Immunol 2008; 15: 1031- 1033.
APA ARABACI F, OLDACAY M (2012). Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. , 50 - 56.
Chicago ARABACI Filiz,OLDACAY Mehmet Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. (2012): 50 - 56.
MLA ARABACI Filiz,OLDACAY Mehmet Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. , 2012, ss.50 - 56.
AMA ARABACI F,OLDACAY M Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. . 2012; 50 - 56.
Vancouver ARABACI F,OLDACAY M Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. . 2012; 50 - 56.
IEEE ARABACI F,OLDACAY M "Evaluation of serological diagnostic tests for human Brucellosis in an endemic area." , ss.50 - 56, 2012.
ISNAD ARABACI, Filiz - OLDACAY, Mehmet. "Evaluation of serological diagnostic tests for human Brucellosis in an endemic area". (2012), 50-56.
APA ARABACI F, OLDACAY M (2012). Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. Journal of Microbiology and Infectious Diseases, 2(2), 50 - 56.
Chicago ARABACI Filiz,OLDACAY Mehmet Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. Journal of Microbiology and Infectious Diseases 2, no.2 (2012): 50 - 56.
MLA ARABACI Filiz,OLDACAY Mehmet Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. Journal of Microbiology and Infectious Diseases, vol.2, no.2, 2012, ss.50 - 56.
AMA ARABACI F,OLDACAY M Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. Journal of Microbiology and Infectious Diseases. 2012; 2(2): 50 - 56.
Vancouver ARABACI F,OLDACAY M Evaluation of serological diagnostic tests for human Brucellosis in an endemic area. Journal of Microbiology and Infectious Diseases. 2012; 2(2): 50 - 56.
IEEE ARABACI F,OLDACAY M "Evaluation of serological diagnostic tests for human Brucellosis in an endemic area." Journal of Microbiology and Infectious Diseases, 2, ss.50 - 56, 2012.
ISNAD ARABACI, Filiz - OLDACAY, Mehmet. "Evaluation of serological diagnostic tests for human Brucellosis in an endemic area". Journal of Microbiology and Infectious Diseases 2/2 (2012), 50-56.